Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.

Open accessibility options menu
  • 24/7
  • Buzz
  • Startups
  • VC
  • Finance@
  • Work@
  • Innovation
  • Opinions
  • Search
  • cleanSearch
  • Accesabillty
  • calcalist logo
bycalcalist logo
  • Homepage
  • Tags search
  • Clal

CTech 24/7

  • “If the campaign will be short-lived, foreign capital will flow into Israel, and new investments will follow”
  • Despite war, Tel Aviv stocks outpace Wall Street in 2025
  • From Safe Superintelligence to Thinking Machines, everyone’s saying no to Meta
  • CTech's War Room: Live Log - June 23, 2025
More stories in CTech

Clal

5 stories about Clal
  •  הוועידה הכלכלית לאומית אמיר ארגמן אסטרטג השקעות ראשי כלל ביטוח ופיננסים

    "Anyone who believes that central banks should halt interest rate hikes lacks an understanding of history"

    18.07.23|Irad Atzmon SchmayerHead of Global Marketing Strategy at Clal Insurance, Amir Argaman, discussed the resurgence of global inflation at Calcalist and Bank Leumi's National Economic Conference

  • הוועידה הכלכלית לאומית יורם נוה מנכ"ל קבוצת כלל ביטוח ופיננסים

    Clal CEO: "2024 will be a great year for Clal"

    18.07.23|Tomer HadarCEO of Clal Insurance Yoram Naveh spoke at Calcalist and Bank Leumi’s National Economic Conference about Clal’s recent acquisition of the Max credit card company

  • Elite Caspi. Photo: Yariv Katz

    Insurance Companies Are Not Dinosaurs, Clal Exec Says

    27.11.19|Anat DanieliElite Caspi, deputy general manager of Israel-based insurance company Clal, spoke Monday at Calcalist’s Mind the Tech conference in Tel Aviv

  • Dani Naveh, chairman of Israeli insurance company Clal. Photo: Amit Sha'al

    Israel Should Encourage Institutionals to Invest in Infrastructure, Says Chairman of Insurer Clal

    03.09.19|Ran AbramsonDani Naveh, chairman of Israeli insurance company Clal, spoke Monday at Calcalist and Bank Leumi's National Economic Conference held in Tel Aviv

  • Hospital (Illustrative). Photo: Tommy Harpaz

    InSight Biopharmaceuticals Buys Cancer Treatment Company CureTech

    28.03.18|Lilach BaumerAs part of the deal, InSight commits to help develop CureTech’s lead product, which is currently in advanced clinical trials

Load more
Ctech Logo
Twitter
Twitter
Facebook
Facebook
NewsLetter
Newsletter
Contact Us
Contact Us
Rss
Rss
About CTech Terms of Use Privacy Policy
Developed by YIT UI & UX by Basch_Interactive